Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > EBITDA / Interest Expenses

Acadia Pharmaceutica EBITDA / Interest Expenses Chart (ACAD)

Acadia Pharmaceutica annual/quarterly EBITDA / Interest Expenses from 2020 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Acadia Pharmaceutica EBITDA / Interest Expenses for the last 12 months ending September 09, 2010 was $-240m
Other Ratios Metrics:
  • Acadia Pharmaceutica Total Debt / Capital for the quarter ending September 09, 2012 was $0m a -708.88% decrease of 0m year over year
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
  • Acadia Pharmaceutica Total Debt / Equity for the quarter ending September 09, 2012 was $0m a -710.06% decrease of 0m year over year
View Chart On Koyfin